ArticleFrontiers in oncology2020

Moderately Hypofractionated Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost for Prostate Cancer: Five-Year Toxicity Results From a Prospective Phase I/II Trial.

Anthony Ricco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.